Low dose of Pfizer-BioNTech vaccine is safe and effective in children ages 5 to 11, companies’ study finds

September 20, 2021 10:46 UTC

Trending Today

It’s a Hard Forkin’ Christmas!

Did DOGE Really Cut Government Spending?

NYT Connections hints and answers for December 22, Tips to solve 'Connections' #925.

Why movie stars are dressing more like movie characters on the red carpet

Low dose of Pfizer-BioNTech vaccine is safe and effective in children ages 5 to 11, companies’ study finds

The Washington Post is providing this news free to all readers as a public service. Follow this story and more by signing up for national breaking news email alerts.

Source: Washington Post September 20, 2021 10:46 UTC

Covid-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer says

Covid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says

Op-Ed: The common thread between L.A.’s 1976 carpool fiasco and anti-vax protests